Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer.

Sano D, Xie TX, Ow TJ, Zhao M, Pickering CR, Zhou G, Sandulache VC, Wheeler DA, Gibbs RA, Caulin C, Myers JN.

Clin Cancer Res. 2011 Nov 1;17(21):6658-70. doi: 10.1158/1078-0432.CCR-11-0046. Epub 2011 Sep 8.

2.

The prognostic significance of p16 overexpression in oropharyngeal squamous cell carcinoma: implications for treatment strategies and future clinical studies.

Langendijk JA, Psyrri A.

Ann Oncol. 2010 Oct;21(10):1931-4. doi: 10.1093/annonc/mdq439. Epub 2010 Aug 17. No abstract available.

PMID:
20716626
3.

Cancer statistics, 2010.

Jemal A, Siegel R, Xu J, Ward E.

CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7. Erratum in: CA Cancer J Clin. 2011 Mar-Apr;61(2):133-4.

4.

Human papillomavirus and survival of patients with oropharyngeal cancer.

Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML.

N Engl J Med. 2010 Jul 1;363(1):24-35. doi: 10.1056/NEJMoa0912217. Epub 2010 Jun 7.

5.

HPV-associated head and neck cancer: a virus-related cancer epidemic.

Marur S, D'Souza G, Westra WH, Forastiere AA.

Lancet Oncol. 2010 Aug;11(8):781-9. doi: 10.1016/S1470-2045(10)70017-6. Epub 2010 May 5. Review.

6.

Check your cultures! A list of cross-contaminated or misidentified cell lines.

Capes-Davis A, Theodosopoulos G, Atkin I, Drexler HG, Kohara A, MacLeod RA, Masters JR, Nakamura Y, Reid YA, Reddel RR, Freshney RI.

Int J Cancer. 2010 Jul 1;127(1):1-8. doi: 10.1002/ijc.25242. Review.

7.

Cell line cross-contamination initiative: an interactive reference database of STR profiles covering common cancer cell lines.

Dirks WG, MacLeod RA, Nakamura Y, Kohara A, Reid Y, Milch H, Drexler HG, Mizusawa H.

Int J Cancer. 2010 Jan 1;126(1):303-4. doi: 10.1002/ijc.24999. No abstract available.

8.

Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines.

Brenner JC, Graham MP, Kumar B, Saunders LM, Kupfer R, Lyons RH, Bradford CR, Carey TE.

Head Neck. 2010 Apr;32(4):417-26. doi: 10.1002/hed.21198.

9.

Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT.

Gupta AK, Lee JH, Wilke WW, Quon H, Smith G, Maity A, Buatti JM, Spitz DR.

Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):928-33. doi: 10.1016/j.ijrobp.2009.03.004.

10.

DNA fingerprinting of the NCI-60 cell line panel.

Lorenzi PL, Reinhold WC, Varma S, Hutchinson AA, Pommier Y, Chanock SJ, Weinstein JN.

Mol Cancer Ther. 2009 Apr;8(4):713-24. doi: 10.1158/1535-7163.MCT-08-0921.

11.

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.

Polyak K, Weinberg RA.

Nat Rev Cancer. 2009 Apr;9(4):265-73. doi: 10.1038/nrc2620. Epub 2009 Mar 5. Review.

PMID:
19262571
12.

Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.

Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow LA, Copland JA, Smallridge RC, Haugen BR.

J Clin Endocrinol Metab. 2008 Nov;93(11):4331-41. doi: 10.1210/jc.2008-1102. Epub 2008 Aug 19.

13.

TP53 mutations and survival in squamous-cell carcinoma of the head and neck.

Poeta ML, Manola J, Goldwasser MA, Forastiere A, Benoit N, Califano JA, Ridge JA, Goodwin J, Kenady D, Saunders J, Westra W, Sidransky D, Koch WM.

N Engl J Med. 2007 Dec 20;357(25):2552-61.

14.

Persistent use of "false" cell lines.

Lacroix M.

Int J Cancer. 2008 Jan 1;122(1):1-4. Review.

15.

Salivary gland tumors in an Iranian population: a retrospective study of 130 cases.

Ansari MH.

J Oral Maxillofac Surg. 2007 Nov;65(11):2187-94.

PMID:
17954313
17.

Case-control study of human papillomavirus and oropharyngeal cancer.

D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML.

N Engl J Med. 2007 May 10;356(19):1944-56.

18.

Head and neck squamous cell carcinoma cell lines: established models and rationale for selection.

Lin CJ, Grandis JR, Carey TE, Gollin SM, Whiteside TL, Koch WM, Ferris RL, Lai SY.

Head Neck. 2007 Feb;29(2):163-88. Review.

19.

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.

Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, Olivier M.

Hum Mutat. 2007 Jun;28(6):622-9.

PMID:
17311302
20.

Overexpression of NBS1 induces epithelial-mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer.

Yang MH, Chang SY, Chiou SH, Liu CJ, Chi CW, Chen PM, Teng SC, Wu KJ.

Oncogene. 2007 Mar 1;26(10):1459-67. Epub 2006 Aug 28.

PMID:
16936774

Supplemental Content

Support Center